Loading…

Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke

Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihyperte...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Nepal Medical Association 2015-03, Vol.53 (197), p.5-11
Main Authors: Poudel, R S, Thapa, L, Shrestha, S, Khatiwada, D, Upadhyay, N, Bhandari, T R, Shrestha, A
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1650-95db30028573e3cf1e95b6117a160228165f4b47aaf947cbb8e0d6e32aa099cc3
cites
container_end_page 11
container_issue 197
container_start_page 5
container_title Journal of Nepal Medical Association
container_volume 53
creator Poudel, R S
Thapa, L
Shrestha, S
Khatiwada, D
Upadhyay, N
Bhandari, T R
Shrestha, A
description Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihypertensive drugs) in acute ischemic stroke patients for the first time and to assess the risk factors present in those patients. The study was conducted on 37 acute ischemic stroke patients admitted and treated at the Neurology Department of College of Medical Sciences-Teaching Hospital, Chitwan, Nepal and they were followed at three months (90±10 days). The initial stroke severity and functional disability were evaluated at admission and at 3 months using National Institute of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) respectively. The outcome parameters were functional independence (mRS≤2) and mortality at three months (mRS=6). Frequency distribution, Mann-Whitney U-test and χ2 test were performed for statistical analysis. Out of 37 patients, 27 (73%) were Smoker, 22 (59.5%) had hypertension and 19 (51.4%) were alcohol consumer. The stroke severity on admission was statistically significant with functional independence (P=0.003) and mortality (P=0.015) at three month. Similarly, Rankin grade on admission was statistically significant with functional independence (P=0.001) and mortality (P=0.048) at three month. At three months, 20 (69%) survived patients were independent while mortality was seen in eight (21.6%) patients. The management of acute ischemic stroke with combined anti-thrombotic, statins and antihypertensive drugs seems promising and efficacious in mild to moderately severe ischemic stroke.
doi_str_mv 10.31729/jnma.2696
format article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6c604f8a09ed469e97469dac8dbab210</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6c604f8a09ed469e97469dac8dbab210</doaj_id><sourcerecordid>26983040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1650-95db30028573e3cf1e95b6117a160228165f4b47aaf947cbb8e0d6e32aa099cc3</originalsourceid><addsrcrecordid>eNo9kE1PwzAMhiMEgvFx4QegnBEdSdomzXEaAyYhcQAkbpWTOpBB2ynpkPbvyTbYxZbtx6_sl5BLzsY5V0LfLroWxkJqeUBGvOJlJpV4PyQjxkSVCcXLE3Ia44KxgquyPCYnia1yVrARgZlz3oJd097Rad8a32FDJ93gh8-Qyn7w9oa-DDD4LlLodrPscb3EMGAX_Q_Su7D6iNR3dGJXA9J5tJ_Yepu2Qv-F5-TIwXfEi798Rt7uZ6_Tx-zp-WE-nTxllsuSZbpsTL45uFQ55tZx1KWRnCvgkglRJcgVplAAThfKGlMhayTmAoBpbW1-RuY73aaHRb0MvoWwrnvw9bbRh48aQvrmG2tpJStclRaxKaRGrVJswFaNASM4S1rXOy0b-hgDur0eZ_XW83rjeb3xPMFXO3i5Mi02e_Tf5PwX8SB8_w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke</title><source>IngentaConnect Journals</source><creator>Poudel, R S ; Thapa, L ; Shrestha, S ; Khatiwada, D ; Upadhyay, N ; Bhandari, T R ; Shrestha, A</creator><creatorcontrib>Poudel, R S ; Thapa, L ; Shrestha, S ; Khatiwada, D ; Upadhyay, N ; Bhandari, T R ; Shrestha, A</creatorcontrib><description>Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihypertensive drugs) in acute ischemic stroke patients for the first time and to assess the risk factors present in those patients. The study was conducted on 37 acute ischemic stroke patients admitted and treated at the Neurology Department of College of Medical Sciences-Teaching Hospital, Chitwan, Nepal and they were followed at three months (90±10 days). The initial stroke severity and functional disability were evaluated at admission and at 3 months using National Institute of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) respectively. The outcome parameters were functional independence (mRS≤2) and mortality at three months (mRS=6). Frequency distribution, Mann-Whitney U-test and χ2 test were performed for statistical analysis. Out of 37 patients, 27 (73%) were Smoker, 22 (59.5%) had hypertension and 19 (51.4%) were alcohol consumer. The stroke severity on admission was statistically significant with functional independence (P=0.003) and mortality (P=0.015) at three month. Similarly, Rankin grade on admission was statistically significant with functional independence (P=0.001) and mortality (P=0.048) at three month. At three months, 20 (69%) survived patients were independent while mortality was seen in eight (21.6%) patients. The management of acute ischemic stroke with combined anti-thrombotic, statins and antihypertensive drugs seems promising and efficacious in mild to moderately severe ischemic stroke.</description><identifier>ISSN: 0028-2715</identifier><identifier>EISSN: 1815-672X</identifier><identifier>DOI: 10.31729/jnma.2696</identifier><identifier>PMID: 26983040</identifier><language>eng</language><publisher>Nepal: Nepal Medical Association</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antihypertensive Agents - therapeutic use ; antihypertensive; anti-thrombotic; efficacy ; statins; stroke ; Brain Ischemia - diagnosis ; Brain Ischemia - drug therapy ; Brain Ischemia - mortality ; Cross-Sectional Studies ; Drug Therapy, Combination ; Female ; Fibrinolytic Agents - therapeutic use ; Follow-Up Studies ; Hospitals, University ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; Male ; Middle Aged ; Nepal ; Prospective Studies ; Risk Factors ; Severity of Illness Index ; Stroke - diagnosis ; Stroke - drug therapy ; Stroke - mortality ; Survival Analysis ; Treatment Outcome</subject><ispartof>Journal of Nepal Medical Association, 2015-03, Vol.53 (197), p.5-11</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1650-95db30028573e3cf1e95b6117a160228165f4b47aaf947cbb8e0d6e32aa099cc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26983040$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poudel, R S</creatorcontrib><creatorcontrib>Thapa, L</creatorcontrib><creatorcontrib>Shrestha, S</creatorcontrib><creatorcontrib>Khatiwada, D</creatorcontrib><creatorcontrib>Upadhyay, N</creatorcontrib><creatorcontrib>Bhandari, T R</creatorcontrib><creatorcontrib>Shrestha, A</creatorcontrib><title>Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke</title><title>Journal of Nepal Medical Association</title><addtitle>JNMA J Nepal Med Assoc</addtitle><description>Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihypertensive drugs) in acute ischemic stroke patients for the first time and to assess the risk factors present in those patients. The study was conducted on 37 acute ischemic stroke patients admitted and treated at the Neurology Department of College of Medical Sciences-Teaching Hospital, Chitwan, Nepal and they were followed at three months (90±10 days). The initial stroke severity and functional disability were evaluated at admission and at 3 months using National Institute of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) respectively. The outcome parameters were functional independence (mRS≤2) and mortality at three months (mRS=6). Frequency distribution, Mann-Whitney U-test and χ2 test were performed for statistical analysis. Out of 37 patients, 27 (73%) were Smoker, 22 (59.5%) had hypertension and 19 (51.4%) were alcohol consumer. The stroke severity on admission was statistically significant with functional independence (P=0.003) and mortality (P=0.015) at three month. Similarly, Rankin grade on admission was statistically significant with functional independence (P=0.001) and mortality (P=0.048) at three month. At three months, 20 (69%) survived patients were independent while mortality was seen in eight (21.6%) patients. The management of acute ischemic stroke with combined anti-thrombotic, statins and antihypertensive drugs seems promising and efficacious in mild to moderately severe ischemic stroke.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>antihypertensive; anti-thrombotic; efficacy ; statins; stroke</subject><subject>Brain Ischemia - diagnosis</subject><subject>Brain Ischemia - drug therapy</subject><subject>Brain Ischemia - mortality</subject><subject>Cross-Sectional Studies</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Follow-Up Studies</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nepal</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Stroke - diagnosis</subject><subject>Stroke - drug therapy</subject><subject>Stroke - mortality</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>0028-2715</issn><issn>1815-672X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9kE1PwzAMhiMEgvFx4QegnBEdSdomzXEaAyYhcQAkbpWTOpBB2ynpkPbvyTbYxZbtx6_sl5BLzsY5V0LfLroWxkJqeUBGvOJlJpV4PyQjxkSVCcXLE3Ia44KxgquyPCYnia1yVrARgZlz3oJd097Rad8a32FDJ93gh8-Qyn7w9oa-DDD4LlLodrPscb3EMGAX_Q_Su7D6iNR3dGJXA9J5tJ_Yepu2Qv-F5-TIwXfEi798Rt7uZ6_Tx-zp-WE-nTxllsuSZbpsTL45uFQ55tZx1KWRnCvgkglRJcgVplAAThfKGlMhayTmAoBpbW1-RuY73aaHRb0MvoWwrnvw9bbRh48aQvrmG2tpJStclRaxKaRGrVJswFaNASM4S1rXOy0b-hgDur0eZ_XW83rjeb3xPMFXO3i5Mi02e_Tf5PwX8SB8_w</recordid><startdate>20150331</startdate><enddate>20150331</enddate><creator>Poudel, R S</creator><creator>Thapa, L</creator><creator>Shrestha, S</creator><creator>Khatiwada, D</creator><creator>Upadhyay, N</creator><creator>Bhandari, T R</creator><creator>Shrestha, A</creator><general>Nepal Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>20150331</creationdate><title>Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke</title><author>Poudel, R S ; Thapa, L ; Shrestha, S ; Khatiwada, D ; Upadhyay, N ; Bhandari, T R ; Shrestha, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1650-95db30028573e3cf1e95b6117a160228165f4b47aaf947cbb8e0d6e32aa099cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>antihypertensive; anti-thrombotic; efficacy ; statins; stroke</topic><topic>Brain Ischemia - diagnosis</topic><topic>Brain Ischemia - drug therapy</topic><topic>Brain Ischemia - mortality</topic><topic>Cross-Sectional Studies</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Follow-Up Studies</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nepal</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Stroke - diagnosis</topic><topic>Stroke - drug therapy</topic><topic>Stroke - mortality</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poudel, R S</creatorcontrib><creatorcontrib>Thapa, L</creatorcontrib><creatorcontrib>Shrestha, S</creatorcontrib><creatorcontrib>Khatiwada, D</creatorcontrib><creatorcontrib>Upadhyay, N</creatorcontrib><creatorcontrib>Bhandari, T R</creatorcontrib><creatorcontrib>Shrestha, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Directory of Open Access Journals</collection><jtitle>Journal of Nepal Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poudel, R S</au><au>Thapa, L</au><au>Shrestha, S</au><au>Khatiwada, D</au><au>Upadhyay, N</au><au>Bhandari, T R</au><au>Shrestha, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke</atitle><jtitle>Journal of Nepal Medical Association</jtitle><addtitle>JNMA J Nepal Med Assoc</addtitle><date>2015-03-31</date><risdate>2015</risdate><volume>53</volume><issue>197</issue><spage>5</spage><epage>11</epage><pages>5-11</pages><issn>0028-2715</issn><eissn>1815-672X</eissn><abstract>Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihypertensive drugs) in acute ischemic stroke patients for the first time and to assess the risk factors present in those patients. The study was conducted on 37 acute ischemic stroke patients admitted and treated at the Neurology Department of College of Medical Sciences-Teaching Hospital, Chitwan, Nepal and they were followed at three months (90±10 days). The initial stroke severity and functional disability were evaluated at admission and at 3 months using National Institute of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) respectively. The outcome parameters were functional independence (mRS≤2) and mortality at three months (mRS=6). Frequency distribution, Mann-Whitney U-test and χ2 test were performed for statistical analysis. Out of 37 patients, 27 (73%) were Smoker, 22 (59.5%) had hypertension and 19 (51.4%) were alcohol consumer. The stroke severity on admission was statistically significant with functional independence (P=0.003) and mortality (P=0.015) at three month. Similarly, Rankin grade on admission was statistically significant with functional independence (P=0.001) and mortality (P=0.048) at three month. At three months, 20 (69%) survived patients were independent while mortality was seen in eight (21.6%) patients. The management of acute ischemic stroke with combined anti-thrombotic, statins and antihypertensive drugs seems promising and efficacious in mild to moderately severe ischemic stroke.</abstract><cop>Nepal</cop><pub>Nepal Medical Association</pub><pmid>26983040</pmid><doi>10.31729/jnma.2696</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-2715
ispartof Journal of Nepal Medical Association, 2015-03, Vol.53 (197), p.5-11
issn 0028-2715
1815-672X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6c604f8a09ed469e97469dac8dbab210
source IngentaConnect Journals
subjects Adult
Aged
Aged, 80 and over
Antihypertensive Agents - therapeutic use
antihypertensive
anti-thrombotic
efficacy
statins
stroke
Brain Ischemia - diagnosis
Brain Ischemia - drug therapy
Brain Ischemia - mortality
Cross-Sectional Studies
Drug Therapy, Combination
Female
Fibrinolytic Agents - therapeutic use
Follow-Up Studies
Hospitals, University
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Male
Middle Aged
Nepal
Prospective Studies
Risk Factors
Severity of Illness Index
Stroke - diagnosis
Stroke - drug therapy
Stroke - mortality
Survival Analysis
Treatment Outcome
title Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A45%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20Combined%20Antithrombotic,%20Statins%20and%20Anti-Hypertensive%20Drugs%20in%20Acute%20Ischemic%20Stroke&rft.jtitle=Journal%20of%20Nepal%20Medical%20Association&rft.au=Poudel,%20R%20S&rft.date=2015-03-31&rft.volume=53&rft.issue=197&rft.spage=5&rft.epage=11&rft.pages=5-11&rft.issn=0028-2715&rft.eissn=1815-672X&rft_id=info:doi/10.31729/jnma.2696&rft_dat=%3Cpubmed_doaj_%3E26983040%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1650-95db30028573e3cf1e95b6117a160228165f4b47aaf947cbb8e0d6e32aa099cc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/26983040&rfr_iscdi=true